期刊文献+

中西医结合疗法对2型糖尿病患者血清胰高糖素样多肽水平的影响 被引量:1

下载PDF
导出
摘要 目的:观察中西医结合疗法对2型糖尿病患者血清胰高糖素样多肽水平的影响;方法:选取2型糖尿病患者31例,均给予生活方式干预、西药降糖治疗及中药口服治疗。结果:患者基线GLP-1浓度与空腹C-肽水平成正相关,而与体质量指数无相关性。结论:中西医结合治疗能改善患者血清GLP-1水平,GLP-1为中西药联合治疗T2D的靶点之一。
作者 王昕 陈轼
机构地区 江苏省中医院
出处 《河南中医》 2014年第9期1812-1814,共3页 Henan Traditional Chinese Medicine
基金 江苏省高校自然科学基金项目(编号:11KJB360003)
  • 相关文献

参考文献12

  • 1Burcelin R, Gourdy P, Dalle S. GLP - 1 - Based Strategies : A Phys- iological Analysis of Differential Mode of Action [ J]. Physiology, 2014,29(2) :108 - 121.
  • 2Sivaraman S C,Barber T M,Ofare P,et al. Glucagon - like pep- tide- 1 -based therapies:effects beyond blood glucose control:re- view[ J]. South African Journal of Diabetes and Vascular Disease, 2014,11(1) :27 -32.
  • 3Donsmark M, Knudsen L B. Lixisenatide in the treatment of type 2 diabetes[ J]. Expert Review of Endocrinology & Metabolism,2014, 46(1) :1 -3.
  • 4Kem E, VanWagner L B, Yang G Y, et al. Liraglutide - Induced Autoimmune Hepatitis [ J ]. JAMA Internal Medicine, 2014, 63 (12) :1159 -1162.
  • 5Egan A G, Blind E, Dunder K, et al. Pancreatic safety of incretin - based drugs--FDA and EMA assessment [ J]. New England Journal of Medicine ,2014,370 (9) :794 - 797.
  • 6仝小林,毕桂芝,甄仲,常柏,刘霞,翟翌,陈良,董柳,李红皎,于波,王佳,周立波,张燕妮.2518例肥胖2型糖尿病中医证型分类研究[J].世界中西医结合杂志,2008,3(1):26-28. 被引量:65
  • 7赵天豫,段军,仝小林.中医治疗糖尿病的新思路[J].光明中医,2002,17(5):12-13. 被引量:24
  • 8Seifarth C, Bergmann J, Hoist J J, et al. Prolonged and enhanced se- cretion of glucagon - like peptide 1 ( 7 - 36 amide) after oral su- crose due to α - glucosidase inhibition (acarbose) in Type 2 dia- betic patients [J]. Diabetic medicine, 1998,15 (6) :485 - 491.
  • 9Hogan A E, Gaoatswe G, Lynch L, et al. Glucagon - hke peptide 1 analogue therapy directly modulates innate immune - mediated in- flammation in individuals with type 2 diabetes mellitus [ J ]. Diabe- talogia,2013,119( 1 ) :1 - 4.
  • 10Yamaoka - Tojo M, Tojo T, Takabira N, et al. Original investiga- tion Elevated circulating levels of an incretin hormone, glucagon - like peptide - l ,are associated with metabolic components in high -risk patients with cardiovascular disease [ J ], Diabetologia, 2010,116(16) :2727 -2730.

二级参考文献11

共引文献86

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部